10-87933143-G-C
Variant summary
Our verdict is Pathogenic. Variant got 19 ACMG points: 19P and 0B. PM1PM2PM5PP2PP3_StrongPP5_Very_Strong
The NM_000314.8(PTEN):c.384G>C(p.Lys128Asn) variant causes a missense change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K128E) has been classified as Pathogenic.
Frequency
Consequence
NM_000314.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PTEN | NM_000314.8 | c.384G>C | p.Lys128Asn | missense_variant | Exon 5 of 9 | ENST00000371953.8 | NP_000305.3 | |
PTEN | NM_001304717.5 | c.903G>C | p.Lys301Asn | missense_variant | Exon 6 of 10 | NP_001291646.4 | ||
PTEN | NM_001304718.2 | c.-367G>C | 5_prime_UTR_variant | Exon 4 of 9 | NP_001291647.1 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
PTEN hamartoma tumor syndrome Pathogenic:1
This variant has been reported as de novo in an individual with symptoms consistent with Bannayan-Riley-Ruvalcaba syndrome (PMID: 17526800). It has also been reported in individuals affected with Cowden syndrome or Cowden syndrome-like symptoms (PMID: 25669429, 23399955). ClinVar contains an entry for this variant (Variation ID: 428220). In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. This variant is not present in population databases (ExAC no frequency). This sequence change replaces lysine with asparagine at codon 128 of the PTEN protein (p.Lys128Asn). The lysine residue is highly conserved and there is a moderate physicochemical difference between lysine and asparagine. An experimental study in yeast cells has shown that this missense change, as well as other amino acid substitutions at this residue (p.Lys128Ala, p.Lys128Arg, p.Lys128Thr), disrupts the PIP3 phosphatase activity of the PTEN protein (PMID: 21828076). -
Hereditary cancer-predisposing syndrome Pathogenic:1
The p.K128N variant (also known as c.384G>C), located in coding exon 5 of the PTEN gene, results from a G to C substitution at nucleotide position 384. The lysine at codon 128 is replaced by asparagine, an amino acid with similar properties. This variant has been observed in multiple individuals with a personal history that is consistent with PTEN hamartoma tumor syndrome, and was noted to be de novo in at least one patient (Ambry internal data; Lachlan KL et al. J. Med. Genet. 2007 Sep;44(9):579-85; Ngeow J et al. J. Clin. Oncol. 2014 Jun;32(17):1818-24; Nizialek EA et al. Eur. J. Hum. Genet. 2015 Nov; 23(11):1538-43). This variant produced a partially inactive protein in an in vivo yeast functional assay (Rodríguez-Escudero I et al. Hum Mol Genet, 2011 Nov;20:4132-42). In a massively parallel functional assay using a humanized yeast model, lipid phosphatase activity for this variant was functionally deficient (Mighell TL et al. Am J Hum Genet, 2018 May;102:943-955). This variant is considered to be rare based on population cohorts in the Genome Aggregation Database (gnomAD). This amino acid position is highly conserved in available vertebrate species. In addition, the in silico prediction for this alteration is inconclusive. Based on the majority of available evidence to date, this variant is likely to be pathogenic. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at